Drugs / LSD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05964647 Comparator | Feb 2024 → Jun 2025 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LSD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05964647 ↗ |
| Route | Oral | “Drug: LSD (150 µg) per os, single dose” NCT05964647 ↗ |